U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494578) titled 'Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC' on July 17, 2025.
Brief Summary: This study will enroll patients with metastatic colorectal cancer treated with the combination of Trifluridine/Tipiracile and Bevacizumab across 15 italian centers.
Study Start Date: July 01, 2025
Study Type: OBSERVATIONAL
Condition:
Colon Cancer Metastatic
Intervention:
DRUG: Fluoropyrimidine
Treatment with fluoropyrimidines and bevacizumab
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Information provided by (Responsible...